"In May last year, the men were injected with heart muscle cells derived from induced pluripotent stem (iPS) cells, the surgeon told Nature — the first known clinical application of iPS-cell technology for treating damaged hearts. ... In January, a cardiac surgeon in Japan, Yoshiki Sawa, introduced iPS-derived cardiomyocytes designed to treat heart disease into a patient — which media reported at the time was a world first. His team is using an alternative approach in which sheets of cells are grafted onto the heart rather than injected into the organ."
Revealed: two men in China were first to receive pioneering stem-cell treatment for heart disease The men are reportedly doing well one year on, but there is no way to confirm that the unpublished treatment using ‘reprogrammed’ stem cells works.
No comments:
Post a Comment